Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Annual Review of Microbiology
|
January 1, 1990
Bioactive microbial products: focus upon mechanism of action
R L Monaghan, J S Tkacz
Journal of Industrial Microbiology
|
February 1, 1993
Improvement in the titer of echinocandin-type antibiotics: a magnesium-limited medium supporting the biphasic production of pneumocandins A0 and B0
J S Tkacz, R A Giacobbe, R L Monaghan
The Journal of Antibiotics
|
January 1, 1993
Microbial hydroxylation and glucuronidation of the angiotensin II (AII) receptor antagonist MK 954
T S Chen, L So, R White, et al.
Nature: New Biology
|
September 19, 1973
Chitosanase, a novel enzyme
R L Monaghan, D E Eveleigh, R P Tewari, et al.
The Journal of Antibiotics
|
February 1, 1989
L-671,329, a new antifungal agent. I. Fermentation and isolation
R E Schwartz, R A Giacobbe, J A Bland, et al.
The Journal of Antibiotics
|
January 1, 1992
Microbial transformation of immunosuppressive compounds. I. Desmethylation of FK506 and immunomycin (FR 900520) by Actinoplanes sp. ATCC 53771
T S Chen, B H Arison, L S Wicker, et al.
The Journal of Antibiotics
|
March 1, 1984
[R-(Z)]-4-amino-3-chloro-2-pentenedioic acid, a new antibiotic. Fermentation, isolation and characterization
L Chaiet, B H Arison, R L Monaghan, et al.
The Journal of Antibiotics
|
July 1, 1988
Novel cholecystokinin antagonists from Aspergillus alliaceus. I. Fermentation, isolation, and biological properties
M A Goetz, R L Monaghan, R S Chang, et al.
The Journal of Antibiotics
|
December 1, 1985
Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties
M A Goetz, M Lopez, R L Monaghan, et al.
The Journal of Antibiotics
|
October 1, 1986
L-681,217, a new and novel member of the efrotomycin family of antibiotics
A J Kempf, K E Wilson, O D Hensens, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Annual Review of Microbiology
|
January 1, 1990
Bioactive microbial products: focus upon mechanism of action
R L Monaghan, J S Tkacz
Journal of Industrial Microbiology
|
February 1, 1993
Improvement in the titer of echinocandin-type antibiotics: a magnesium-limited medium supporting the biphasic production of pneumocandins A0 and B0
J S Tkacz, R A Giacobbe, R L Monaghan
The Journal of Antibiotics
|
January 1, 1993
Microbial hydroxylation and glucuronidation of the angiotensin II (AII) receptor antagonist MK 954
T S Chen, L So, R White, et al.
Nature: New Biology
|
September 19, 1973
Chitosanase, a novel enzyme
R L Monaghan, D E Eveleigh, R P Tewari, et al.
The Journal of Antibiotics
|
February 1, 1989
L-671,329, a new antifungal agent. I. Fermentation and isolation
R E Schwartz, R A Giacobbe, J A Bland, et al.
The Journal of Antibiotics
|
January 1, 1992
Microbial transformation of immunosuppressive compounds. I. Desmethylation of FK506 and immunomycin (FR 900520) by Actinoplanes sp. ATCC 53771
T S Chen, B H Arison, L S Wicker, et al.
The Journal of Antibiotics
|
March 1, 1984
[R-(Z)]-4-amino-3-chloro-2-pentenedioic acid, a new antibiotic. Fermentation, isolation and characterization
L Chaiet, B H Arison, R L Monaghan, et al.
The Journal of Antibiotics
|
July 1, 1988
Novel cholecystokinin antagonists from Aspergillus alliaceus. I. Fermentation, isolation, and biological properties
M A Goetz, R L Monaghan, R S Chang, et al.
The Journal of Antibiotics
|
December 1, 1985
Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties
M A Goetz, M Lopez, R L Monaghan, et al.
The Journal of Antibiotics
|
October 1, 1986
L-681,217, a new and novel member of the efrotomycin family of antibiotics
A J Kempf, K E Wilson, O D Hensens, et al.
Page
of 3